AG˹ٷ

STOCK TITAN

[SCHEDULE 13G] Sarepta Therapeutics,, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Veru Inc. (VERU) filed an 8-K disclosing results from its 25 July 2025 special shareholder meeting.

  • Reverse stock split: Shareholders approved an amendment authorising the Board to implement a reverse split at any ratio between 1-for-2 and 1-for-20. Votes: 98,869,209 FOR, 7,080,957 AGAINST, 1,013,920 ABSTAIN; 0 broker non-votes.
  • Adjournment proposal: Also approved with 100,083,638 FOR, 6,212,862 AGAINST, 667,586 ABSTAIN.

Out of 146,583,920 eligible shares, about 106.9 million (�73%) were voted. No other matters were considered.

Veru Inc. (VERU) ha presentato un modulo 8-K comunicando i risultati dell'assemblea speciale degli azionisti tenutasi il 25 luglio 2025.

  • Frazionamento azionario inverso: Gli azionisti hanno approvato una modifica che autorizza il Consiglio di Amministrazione a effettuare un frazionamento inverso con un rapporto compreso tra 1-per-2 e 1-per-20. Voti: 98.869.209 A FAVORE, 7.080.957 CONTRARI, 1.013.920 Astenuti; 0 voti non espressi dai broker.
  • Proposta di rinvio: Approvata anch'essa con 100.083.638 A FAVORE, 6.212.862 CONTRARI, 667.586 Astenuti.

Su 146.583.920 azioni ammissibili, circa 106,9 milioni (�73%) hanno partecipato alla votazione. Non sono stati considerati altri argomenti.

Veru Inc. (VERU) presentó un formulario 8-K divulgando los resultados de su reunión especial de accionistas del 25 de julio de 2025.

  • Consolidación inversa de acciones: Los accionistas aprobaron una enmienda que autoriza a la Junta a implementar una consolidación inversa con una proporción entre 1 por 2 y 1 por 20. Votos: 98,869,209 A FAVOR, 7,080,957 EN CONTRA, 1,013,920 ABSTENCIONES; 0 votos no emitidos por corredores.
  • Propuesta de aplazamiento: También aprobada con 100,083,638 A FAVOR, 6,212,862 EN CONTRA, 667,586 ABSTENCIONES.

De 146,583,920 acciones elegibles, aproximadamente 106.9 millones (�73%) fueron votadas. No se consideraron otros asuntos.

Veru Inc. (VERU)� 2025� 7� 25� 특별 주주총회 결과� 공시하는 8-K 보고서를 제출했습니다.

  • 역주식병�: 주주들은 이사회가 1대 2에서 1대 20 사이� 비율� 역병합을 시행� � 있도� 하는 수정안을 승인했습니다. 투표 결과: 찬성 98,869,209�, 반대 7,080,957�, 기권 1,013,920�; 중개� 미투� 0�.
  • 연기 제안: 찬성 100,083,638�, 반대 6,212,862�, 기권 667,586표로 승인되었습니�.

� 146,583,920� � � 1� 690� �(� 73%)가 투표� 참여했으�, 다른 안건은 다루지 않았습니�.

Veru Inc. (VERU) a déposé un formulaire 8-K divulguant les résultats de son assemblée générale extraordinaire des actionnaires tenue le 25 juillet 2025.

  • Regroupement d'actions inversé : Les actionnaires ont approuvé un amendement autorisant le conseil d'administration à mettre en œuvre un regroupement inversé selon un ratio compris entre 1 pour 2 et 1 pour 20. Votes : 98 869 209 POUR, 7 080 957 CONTRE, 1 013 920 ABSTENTIONS ; 0 votes non exprimés par les courtiers.
  • Proposition de report : Également approuvée avec 100 083 638 POUR, 6 212 862 CONTRE, 667 586 ABSTENTIONS.

Sur 146 583 920 actions éligibles, environ 106,9 millions (�73 %) ont été votées. Aucune autre question n’a été examinée.

Veru Inc. (VERU) hat einen 8-K-Bericht eingereicht, in dem die Ergebnisse der außerordentlichen Hauptversammlung am 25. Juli 2025 bekannt gegeben wurden.

  • Aktienzusammenlegung (Reverse Split): Die Aktionäre genehmigten eine Änderung, die dem Vorstand erlaubt, eine Aktienzusammenlegung im Verhältnis zwischen 1:2 und 1:20 durchzuführen. Stimmen: 98.869.209 FÜR, 7.080.957 GEGEN, 1.013.920 ENTHALTUNGEN; 0 Broker-Nichtstimmen.
  • Vertagungsvorschlag: Ebenfalls genehmigt mit 100.083.638 FÜR, 6.212.862 GEGEN, 667.586 ENTHALTUNGEN.

Von 146.583.920 stimmberechtigten Aktien wurden etwa 106,9 Millionen (�73 %) abgegeben. Weitere Angelegenheiten wurden nicht behandelt.

Positive
  • Strong shareholder support: 92.5% of votes cast favored granting reverse split authority, reflecting confidence in board discretion.
  • Flexible ratio range: Approval covers 1-for-2 to 1-for-20, giving management broad capital-structure options.
Negative
  • None.

Insights

TL;DR: Shareholders grant board wide authority for a reverse split; neutral but increases capital-structure flexibility.

The decisive approval—over 92% of votes cast—gives Veru’s board discretion to choose a split ratio anywhere from 1-for-2 to 1-for-20. While the filing does not specify the board’s intent or timing, the mandate equips management with a tool to alter share count and price when deemed advantageous. Approximately 73% of outstanding shares participated, indicating adequate but not overwhelming engagement. Because no split is immediately effected, today’s disclosure is procedurally important yet financially neutral until the board selects a ratio.

Veru Inc. (VERU) ha presentato un modulo 8-K comunicando i risultati dell'assemblea speciale degli azionisti tenutasi il 25 luglio 2025.

  • Frazionamento azionario inverso: Gli azionisti hanno approvato una modifica che autorizza il Consiglio di Amministrazione a effettuare un frazionamento inverso con un rapporto compreso tra 1-per-2 e 1-per-20. Voti: 98.869.209 A FAVORE, 7.080.957 CONTRARI, 1.013.920 Astenuti; 0 voti non espressi dai broker.
  • Proposta di rinvio: Approvata anch'essa con 100.083.638 A FAVORE, 6.212.862 CONTRARI, 667.586 Astenuti.

Su 146.583.920 azioni ammissibili, circa 106,9 milioni (�73%) hanno partecipato alla votazione. Non sono stati considerati altri argomenti.

Veru Inc. (VERU) presentó un formulario 8-K divulgando los resultados de su reunión especial de accionistas del 25 de julio de 2025.

  • Consolidación inversa de acciones: Los accionistas aprobaron una enmienda que autoriza a la Junta a implementar una consolidación inversa con una proporción entre 1 por 2 y 1 por 20. Votos: 98,869,209 A FAVOR, 7,080,957 EN CONTRA, 1,013,920 ABSTENCIONES; 0 votos no emitidos por corredores.
  • Propuesta de aplazamiento: También aprobada con 100,083,638 A FAVOR, 6,212,862 EN CONTRA, 667,586 ABSTENCIONES.

De 146,583,920 acciones elegibles, aproximadamente 106.9 millones (�73%) fueron votadas. No se consideraron otros asuntos.

Veru Inc. (VERU)� 2025� 7� 25� 특별 주주총회 결과� 공시하는 8-K 보고서를 제출했습니다.

  • 역주식병�: 주주들은 이사회가 1대 2에서 1대 20 사이� 비율� 역병합을 시행� � 있도� 하는 수정안을 승인했습니다. 투표 결과: 찬성 98,869,209�, 반대 7,080,957�, 기권 1,013,920�; 중개� 미투� 0�.
  • 연기 제안: 찬성 100,083,638�, 반대 6,212,862�, 기권 667,586표로 승인되었습니�.

� 146,583,920� � � 1� 690� �(� 73%)가 투표� 참여했으�, 다른 안건은 다루지 않았습니�.

Veru Inc. (VERU) a déposé un formulaire 8-K divulguant les résultats de son assemblée générale extraordinaire des actionnaires tenue le 25 juillet 2025.

  • Regroupement d'actions inversé : Les actionnaires ont approuvé un amendement autorisant le conseil d'administration à mettre en œuvre un regroupement inversé selon un ratio compris entre 1 pour 2 et 1 pour 20. Votes : 98 869 209 POUR, 7 080 957 CONTRE, 1 013 920 ABSTENTIONS ; 0 votes non exprimés par les courtiers.
  • Proposition de report : Également approuvée avec 100 083 638 POUR, 6 212 862 CONTRE, 667 586 ABSTENTIONS.

Sur 146 583 920 actions éligibles, environ 106,9 millions (�73 %) ont été votées. Aucune autre question n’a été examinée.

Veru Inc. (VERU) hat einen 8-K-Bericht eingereicht, in dem die Ergebnisse der außerordentlichen Hauptversammlung am 25. Juli 2025 bekannt gegeben wurden.

  • Aktienzusammenlegung (Reverse Split): Die Aktionäre genehmigten eine Änderung, die dem Vorstand erlaubt, eine Aktienzusammenlegung im Verhältnis zwischen 1:2 und 1:20 durchzuführen. Stimmen: 98.869.209 FÜR, 7.080.957 GEGEN, 1.013.920 ENTHALTUNGEN; 0 Broker-Nichtstimmen.
  • Vertagungsvorschlag: Ebenfalls genehmigt mit 100.083.638 FÜR, 6.212.862 GEGEN, 667.586 ENTHALTUNGEN.

Von 146.583.920 stimmberechtigten Aktien wurden etwa 106,9 Millionen (�73 %) abgegeben. Weitere Angelegenheiten wurden nicht behandelt.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



D. E. Shaw & Co., L.P.
Signature:/s/ Daniel R. Marcus
Name/Title:Daniel R. Marcus / Chief Compliance Officer
Date:07/25/2025
David E. Shaw
Signature:/s/ Daniel R. Marcus
Name/Title:Daniel R. Marcus / Attorney-in-Fact for David E. Shaw
Date:07/25/2025

Comments accompanying signature: Exhibit 1: Power of Attorney, granted by David E. Shaw relating to D. E. Shaw & Co., Inc., in favor of the signatories hereto, among others, dated August 1, 2024.
Exhibit Information

Exhibit 2: Joint Filing Agreement, by and among the Reporting Persons, dated July 25, 2025.

FAQ

What did VERU shareholders approve at the July 25, 2025 special meeting?

They authorized the Board to enact a reverse stock split at a ratio between 1-for-2 and 1-for-20 and approved meeting adjournment.

What were the vote totals for Veru's reverse stock split proposal?

For: 98,869,209; Against: 7,080,957; Abstain: 1,013,920; Broker non-votes: 0.

How many VERU shares were eligible to vote at the special meeting?

A total of 146,583,920 common shares were eligible to vote.

What split ratios can Veru's board now choose?

Any ratio from 1-for-2 to 1-for-20 as approved in the amendment.

Who signed Veru's Form 8-K filing?

Chief Financial Officer and Chief Administrative Officer Michele Greco signed the report.
Sarepta Therapeutics Inc

NASDAQ:SRPT

SRPT Rankings

SRPT Latest News

SRPT Latest SEC Filings

SRPT Stock Data

1.31B
93.93M
4.41%
92.37%
5.22%
Biotechnology
Pharmaceutical Preparations
United States
CAMBRIDGE